Finanzwire Finanzwire
Basculer en Français
10753 Companies
230965 Keywords
159401 Articles
122753 Press releases
Headlines Articles Press releases Clairvoyant Therapeutics Remove
  1. Home
  2. Companies
  3. Clairvoyant Therapeutics
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/03/2024 at 14:05, 2 years 3 months ago

    Clairvoyant Therapeutics Advances Psilocybin Clinical Trial for Alcohol Use Disorder

    Clinical Trial Clairvoyant Therapeutics Psilocybin Treatment Alcohol Use Disorder Regulatory Pathway
  • PRESS RELEASE

    published on 04/03/2024 at 14:00, 2 years 3 months ago

    Psilocybin Clinical Trial Sponsored by Clairvoyant Therapeutics Reaches 90% Randomization

    Clairvoyant Therapeutics aims to commercialize psilocybin treatment for alcohol use disorder by 2025. Company's trial progressing well, expecting results in 2024 & financing round underway
    Commercialization Clinical Trial Clairvoyant Therapeutics Psilocybin Treatment Alcohol Use Disorder
    Logo of Clairvoyant Therapeutics
  • PRESS RELEASE

    published on 11/29/2023 at 13:00, 2 years 7 months ago

    Clairvoyant Surpasses 50 Per Cent Randomization in its Phase 2b Psilocybin Therapy Trial for Alcohol Use Disorder

    Logo of Clairvoyant Therapeutics
  • PRESS RELEASE

    published on 03/20/2023 at 12:00, 3 years 4 months ago

    First Patient Dosed in Europe in Clairvoyant’s Phase 2b Clinical Trial Exploring Psilocybin Therapy as a Treatment for Alcohol Use Disorder

    Logo of Clairvoyant Therapeutics
Accesswire
  • Published on 07/21/2026 at 17:05, 1 hour 12 minutes ago

    Caldwell Appoints Steven Price Co-Leader of Life Sciences & Healthcare Practice

  • Published on 07/21/2026 at 15:00, 3 hours 17 minutes ago

    Four Nines Gold Begins Maiden Drill Program at Hayden Hill

  • Published on 07/21/2026 at 15:00, 3 hours 17 minutes ago

    BlackBerry SecuSUITE Secures Renewed NIAP Common Criteria Certification, Reinforcing Leadership in Sovereign Government-Grade Secure Communications

  • Published on 07/21/2026 at 14:55, 3 hours 22 minutes ago

    Vulcan Minerals Inc. - Drilling Completed at Carbonear Zinc-Lead SEDEX Project in Newfoundland

  • Published on 07/21/2026 at 14:30, 3 hours 47 minutes ago

    Sarama Completes Sale of its West Australian Gold Assets

View all ACCESSWIRE
EQS Group
  • Published on 07/21/2026 at 17:50, 27 minutes ago

    The New Measure of an EV Isn't Range, It's Peace of Mind

  • Published on 07/21/2026 at 17:40, 37 minutes ago

    EQS-Adhoc: Airbus to present new mid-term outlook, strengthen commitment to profitable growth and shareholder returns during investor update

  • Published on 07/21/2026 at 17:37, 39 minutes ago

    EQS-Adhoc: Branicks Group AG updates the timetable for the publication of its 2025 annual and consolidated financial statements in light of ongoing restructuring negotiations

  • Published on 07/21/2026 at 17:16, 1 hour ago

    Fuller, Smith & Turner PLC:

  • Published on 07/21/2026 at 17:07, 1 hour 9 minutes ago

    Dividend Declaration

View all EQS
Les Echos
  • Published on 07/20/2026 at 18:20, 23 hours 57 minutes ago

    Covivio - 2026 Half-year results: Earnings growth driven by active asset management

  • Published on 07/20/2026 at 18:04, 1 day ago

    Reporting on share buyback transactions carried out between July 8 and July 9, 2026

  • Published on 07/20/2026 at 17:45, 1 day ago

    Weekly share buyback

  • Published on 07/20/2026 at 17:40, 1 day ago

    Mersen selected to supply Ford and Leapmotor with fuses for electric vehicles

  • Published on 07/20/2026 at 14:25, 1 day 3 hours ago

    GUILLEMOT CORPORATION | Weekly report share buyback from July 13 to July 17 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy